Key Takeaways
- • Pluro Fertility and IVF raised Rs 125 crore ($14 million) in Series A funding led by Bessemer Venture Partners, valuing the healthcare partnership platform at Rs 1,000 crore ($120 million equivalent).
- • The company plans to establish 25 fertility centres across India by March 2026, expanding access to assisted reproductive technology services through a partnership model with independent IVF specialists.
- • Pluro operates as a tech-enabled fertility-care network founded by Dr. Jaydeep Tank, Dr. Parikshit Tank, and Dr. Bhaskar Shah, positioning itself to serve millions of Indian couples seeking parenthood through a "couple first" care approach.
- • Bessemer Venture Partners' lead investment signals institutional confidence in India's fertility care market and the scalability of Pluro's partnership-based platform model in the underserved Indian healthcare sector.
Summary
Pluro Fertility and IVF, a healthcare partnership platform, has secured Rs 125 crore ($14 million) in Series A funding led by prominent venture capital firm Bessemer Venture Partners. The round values the fertility startup at Rs 1,000 crore, marking a significant milestone in the company's growth trajectory within India's assisted reproductive technology sector. The funding round also included participation from angel investors, though specific names were not disclosed in available sources.
Founded in 2025 by fertility specialists Dr. Jaydeep Tank, Dr. Parikshit Tank, and Dr. Bhaskar Shah, Pluro operates a differentiated business model by creating a technology-enabled network that partners with established, independent fertility and IVF specialists across India. Rather than building proprietary clinics from scratch, the company provides operational infrastructure and digital tools to enhance patient experience and standardize care quality. The founders' clinical backgrounds lend credibility to the platform's mission to deliver high-quality, accessible fertility care.
The capital deployment strategy is ambitious: Pluro plans to establish 25 fertility centres across India by March 2026, substantially expanding the addressable market for assisted reproductive services in a country where fertility care remains concentrated in major metropolitan areas. This expansion aligns with the company's stated objective to help millions of Indian women and men realize parenthood through reliable, world-class fertility treatment solutions. The partnership model with existing specialists enables rapid geographic scaling without requiring the substantial capital expenditure associated with building de novo clinic infrastructure.
Bessemer Venture Partners' leadership of the round underscores institutional investor conviction in both Pluro's execution capability and the broader opportunity in India's fertility care market. The fertility sector in India remains fragmented and underserved relative to demand, with significant quality variation across providers. Pluro's technology-first platform approach and specialist partnership model address this market inefficiency, positioning the startup to capture value as fertility care becomes increasingly digitized and accessible across tier-2 and tier-3 Indian cities.
Founded in 2025 by fertility specialists Dr. Jaydeep Tank, Dr. Parikshit Tank, and Dr. Bhaskar Shah, Pluro operates a differentiated business model by creating a technology-enabled network that partners with established, independent fertility and IVF specialists across India. Rather than building proprietary clinics from scratch, the company provides operational infrastructure and digital tools to enhance patient experience and standardize care quality. The founders' clinical backgrounds lend credibility to the platform's mission to deliver high-quality, accessible fertility care.
The capital deployment strategy is ambitious: Pluro plans to establish 25 fertility centres across India by March 2026, substantially expanding the addressable market for assisted reproductive services in a country where fertility care remains concentrated in major metropolitan areas. This expansion aligns with the company's stated objective to help millions of Indian women and men realize parenthood through reliable, world-class fertility treatment solutions. The partnership model with existing specialists enables rapid geographic scaling without requiring the substantial capital expenditure associated with building de novo clinic infrastructure.
Bessemer Venture Partners' leadership of the round underscores institutional investor conviction in both Pluro's execution capability and the broader opportunity in India's fertility care market. The fertility sector in India remains fragmented and underserved relative to demand, with significant quality variation across providers. Pluro's technology-first platform approach and specialist partnership model address this market inefficiency, positioning the startup to capture value as fertility care becomes increasingly digitized and accessible across tier-2 and tier-3 Indian cities.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.